Compounding Intelligence Layer
Project 777 turns frontier-model capability into validated, reusable intelligence that improves across runs and domains.
For the last three years, the AI industry has focused on building more powerful models. But frontier models are becoming increasingly interchangeable. The durable opportunity now sits above the model: turning raw AI output into intelligence that can be evaluated, retained, improved, and reused.
Project 777 is not another model company.
Project 777 is a model-agnostic compounding intelligence layer above frontier models and agents. Three things make the compounding intelligence layer possible, and they work together:- Runtime Intelligence and Safety Checks: Every output is reviewed while the run is still happening. The system checks whether it stayed on task, whether its claims are supported, whether its sources can be verified, whether it uses the right benchmark when one applies, and whether it follows the rules for that field. Work can pass, be blocked, be sent back for correction, or be held for further review before it moves forward.- Bounded Recursive Self-Improvement: The system improves its own memory, solutions, workflows, and architecture. But the part that proposes an improvement is never the part that approves it — a separate layer measures whether the change actually helped, and it's only kept if the evidence holds.- Cross-Domain Operation. The same core runs across completely different industries without being rebuilt for each one.
The Layer Above Frontier Models
If frontier models are the engines, Project 777 is the intelligence layer that coordinates how those engines operate, what their work must prove, what capability is retained, and how the system improves over time.The underlying model can be changed, combined, or upgraded while Project 777 preserves validated memory, evaluation, auditability, and accumulated intelligence.This creates a strategic asset above interchangeable models rather than tying value to any single model provider.
How We Know the System Produces Real Value
Project 777 has both commercial and measured technical validation.
A $1M+ commercial healthcare license for regulator-ready molecular structures.
The system compares its strongest solutions against defined real-world benchmarks and prior baselines, so improvement is measured rather than assumed.
474 solution packages and run records have been produced across more than 1,000 domains.
20,000+ governance-cleared, review-ready outputs have been generated.
Why this matters now
The market is shifting. Frontier models are increasingly interchangeable. The architectural moat is moving from raw model capability to the infrastructure that can govern, verify, and deploy that intelligence safely at scale.
The next phase of AI will not be defined by the model alone. It will be defined by the architecture that governs intelligence in the real world.
Project 777 is that architecture.
Strategic Conclusion
This is the combination that matters: an architecture that improves within bounds, generalizes across domains, remains governed at runtime, and is independently inspected, verified, and audited.
These results provide evidence of a new class of system: an architecture delivering cross-domain solutions at scale while remaining traceable, auditable, and aligned to human-defined constraints.
Independent Review & Validation
Project 777’s architecture and execution artifacts have undergone independent review across federal technology, regulated AI systems, cloud architecture, cybersecurity, clinical development, and translational medicine. Reviewers include Dr. David Bray (former U.S. Federal CIO), Dr. Roma Shusterman (FDA-regulated medical-device and AI systems executive), Ian Perez Ponce (former AWS technology leader), and Preston Dunlap (former CTO and Chief Architect, U.S. Space Force & Air Force). Additional independent validation includes Rashid Zaman in cybersecurity compliance, Dr. Michael Rosol in clinical development feasibility, Mehmet Tosun, MD, PhD in translational medicine, and Randi Griffin in clinical trial operations.
Founder
TK Stohlman is the founder of Project 777, a model-agnostic compounding intelligence layer that turns frontier-model outputs into validated, reusable intelligence for real-world deployment.
Strategic Transition & Integration
Project 777 is currently supporting technical due diligence and architectural reviews for a limited number of frontier labs, hyperscalers, and institutional partners.
Qualified organizations may request a controlled briefing of execution artifacts and system architecture.
Project777.ai
Project 777 © 2026. All rights reserved.